Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Mol Cell Med
Asıl Yazarlar: Naderi, Malihe, Gholipour, Naghmeh, Zolfaghari, Mohammad Reza, Moradi Binabaj, Maryam, Yegane Moghadam, Ahmad, Motalleb, Gholamreza
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Babol University of Medical Sciences 2014
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293608/
https://ncbi.nlm.nih.gov/pubmed/25635247
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller